ArticleScientific reports2020

Tyrosine kinase inhibitor neratinib attenuates liver fibrosis by targeting activated hepatic stellate cells.

Yong Joo Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.